RajuK(Radha)PillaiMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Hematopathologist and Director, Pathology Bioinformatics

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-256-4673

Fax+1 626-218-5310

UPMC Medical EducationFellowship, Hematopathology, 2010 - 2012
UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2009 - 2010
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 2005 - 2009
Calicut Medical CollegeClass of 1993

PubMed

Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies.
Fei Fei, Milhan Telatar, Vanina Tomasian, Lisa Chang, Mariel Gust
International Journal of Molecular Sciences. 2025-01-07
1 citations
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for Lymphoma.
June-Wha Rhee, Raju Pillai, Sitong Chen, Alysia Bosworth, Artem Oganesyan
JACC. Cardiooncology. 2025-01-01
Dysfunctional β-cell longevity in diabetes relies on energy conservation and positive epistasis.
Kavit Raval, Neema Jamshidi, Berfin Seyran, Lukasz Salwinski, Raju Pillai
Life Science Alliance. 2024-12-01

Journal Articles

ERα-Mediated Cell Cycle Progression Is an Important Requisite for CDK4/6 Inhibitor Response in HR+ Breast Cancer
Joanne Mortimer, Laura Kruper, Raju Pillai, George Somlo, Yuan Yuan, Oncotarget

Abstracts/Posters

Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
Raju Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018